Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- QIPT -5.4%, FCEL -4.6%, FDS -2.7%, ACN -2.0%
Other news:
- BLUE -15.1% (commences $150 mln stock offering)
- INMB -14.4% (Company received notification by the FDA that the US Phase II Alzheimer's trial remains on full clinical hold pending a request for additional information on long-term potency.)
- QURE -6.2% (announces update on phase I/II clinical trials of AMT-130 gene therapy for the treatment of huntington's disease)
- EXK -5.8% (announces at-the-market offering of up to $60 mln)
- MAMA -4.9% (announces pricing of previously announced offering of 5,629,921 shares by selling stockholders at a price to the public of $3.50 per share)
- CCLP -2.4% (Kodiak Gas Services (KGS) to acquire CSI Compressco LP in an $854 million all-equity transaction)
- RYN -2.0% (declares special cash dividend of $0.20/share)
- PR -1.8% (announces secondary public offering of class A common stock)
- ADMA -1.7% (executes definitive credit agreement with Ares Management credit funds for $135 mln in total senior secured credit facilities)
- PAAS -1.4% ( announces preliminary economic assessment of the La Colorada skarn project)
- QRVO -1.2% (Luxshare will acquire Qorvo's assembly and test facilities in China)
Analyst comments:
- PLUG -5.2% (downgraded to Underweight from Neutral at Piper Sandler; tgt lowered to $2.30)
- PTCT -1.1% (downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt $28)
- EQNR -1.0% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)